Company Overview and News

 
Now See Wall Street's 38 'Safer' International Dividend WallStars For April

2h seekingalpha
Wall Street thrives on picking prices for equities. Nearly all my articles include Broker 1yr. Target estimates. This Wall St. Star series was suggested by a reader, Minnesota72. Nationality was.
Upvote Downvote

 
32 Of 74 Communication Services Equities Show 'Safer' Dividends For April

2018-04-15 seekingalpha
Ten 'safer' dividend Communication Services (CS) stock averaged 21.9% gains . Top gainer China Mobile produced a 41.26% net per broker targets 4/11/18.
Upvote Downvote

 
Top 50 Communication Services Stocks For April By Yield And Target Gains

2018-04-13 seekingalpha
Overseas telecom firms remained at the top by gains this month as North American telcos were mid-bound in analyst 1yr. targeting.
Upvote Downvote

 
Telecom industry revenues to dip 9% in FY19: Deutsche Bank

2018-04-13 thehindubusinessline
Telecom industry revenues will decline by 9 per cent to $21.6 billion in FY19 as incumbents continue to calibrate offers to match the plans of Reliance Industries Ltd's telecom unit, Jio, according to Deutsche Bank.
Upvote Downvote

 
M.D.C. Holdings, Inc. (MDC) Sees Hammer Chart Pattern: Time to Buy?

2018-04-11 zacks
M.D.C. Holdings, Inc. (MDC - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because MDC recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
Upvote Downvote

 
Macy's, Inc. (M) Sees Hammer Chart Pattern: Time to Buy?

2018-04-11 zacks
Macy's, Inc. (M - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because M recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
Upvote Downvote

 
LeMaitre Vascular, Inc. (LMAT) Sees Hammer Chart Pattern: Time to Buy?

2018-04-11 zacks
LeMaitre Vascular, Inc. (LMAT - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because LMAT recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
Upvote Downvote

 
Brinker International, Inc. (EAT) Sees Hammer Chart Pattern: Time to Buy?

2018-04-11 zacks
Brinker International, Inc. (EAT - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because EAT recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
Upvote Downvote

 
Columbia Property Trust, Inc. (CXP) Sees Hammer Chart Pattern: Time to Buy?

2018-04-11 zacks
Columbia Property Trust, Inc. (CXP - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because CXP recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
Upvote Downvote

 
Moving Average Crossover Alert: Vodafone Group PLC (VOD)

2018-04-10 zacks
Vodafone Group PLC (VOD - Free Report) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front. Recently, the 50 Day Moving Average for VOD broke out below the 200 Day Simple Moving Average, suggesting short-term bearishness.
Upvote Downvote

 
What Lies Ahead for Telecom ETFs?

2018-03-31 zacks
U.S. telecommunications industry had a disappointing 2017. However, signs of improvement were apparent from fourth-quarter 2017 with most of the major telecommunications stocks starting to perform well. Notably, all four national wireless carriers have gained postpaid subscribers in the last reported quarter.
Upvote Downvote

 
More than a king#39;s ransom: These companies paid billions in MAs

2018-03-29 moneycontrol
Vodafone acquires Mannesmann Group | Year: 2000 | Deal size: USD 180.95 billion | After months of battling takeover, Mannesmann finally accepted Vodafone’s proposal. Mannesmann’s telecommunications arm was incorporated by Vodafone while other divisions were resold soon after the deal. (Image: Reuters)
Upvote Downvote

1
24 'Safer' Dividends Out Of My Readers 49 Most Mentioned Dividend Stocks For March

2018-03-25 seekingalpha
From 2/1-3/5/18, Fredrik Arnold dividend "followers" discussed 49 equities and funds in their messages and comments. Some comments were bad news, so bad rogues mixed into a FollowerFavorite/Rogue (FoFa/Ro) list.
Upvote Downvote

 
Kumar Mangalam Birla to lead Vodafone-Idea combine’s leadership team

2018-03-23 livemint
New Delhi: Vodafone India and Idea Cellular Ltd, which are in the process of a merger, on Thursday outlined the key leadership team which will head the merged entity.
Upvote Downvote

 
Deutsche Telekom, Vodafone Chased by East Europe `Predator' - Bloomberg

2018-03-23 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...